Drugs Pharmacokinetics Indications Contraindicatio N Interaction Adverse Effects Generic Name
Drugs Pharmacokinetics Indications Contraindicatio N Interaction Adverse Effects Generic Name
Drugs Pharmacokinetics Indications Contraindicatio N Interaction Adverse Effects Generic Name
DRUGS INTERACTION
(with dosage) N EFFECTS
ABSORPTION DISTRIBUTION METABOLISM EXCRETION
Generic name:
Impenem Bioavailability: UTI Nausea &
Meropenem NOT absorbed Kidney Kidney 70% RTI Dosage modification Vomiting
Doripenem ORALLY T1/2: 1 hour Intra-abdominal & with renal (Most
common)
ertrapenem Gyne infection insufficiency
Onset:
Duration of Cephalosporin- Seizure(high
Classification: doses in CNS
Carbapenems, Beta- action: rsistant nosocomial lesion)
Lactam antibiotics Impenem(comb infection
with Cilastation which
inhibits impenem
degradation by renal Emperical Tx
Chemistry: contain
fused B-lactam ring and a five-
tubular dipeptidase) serious infections in
member ring system that hosp. patients
differs from penicillins because
it is unsaturated and contains a
Notes:
carbon atom instead of the Meropenem: less active to g(+), more active to g(-), less likely to cause seizure, Preferred Tx of Meningitis when Carbanem is required.
sulfur atom. Doripem: greater activity against some resistant isolates of Pseudomonas.
Broader spectrum of activity
than most other B-lactam Ertrapenem: longer half-life, allows ONCE-daily dosing, good against enterobacteriaceae and anaerobes, useful in intra-abdominal and Pelvic infections.
antibiotic
Generic name: IM/IM T1/2: 1.7 hour kidney Gram negative
Aztreonam unaltered 6h if anephric bacteria only
Classification:
Monobactam 2g q 6-8h
Generic name: For antibiotic
Clavulanate resistant strains
Sulbactam
Tazobactam Most active against
plasmid-encoded B-
Avibactam
lactamase(older B-
lactamses, clavulanate,
Classification: Sulbactam, Tazobactam)
Beta-Lactamase Clavulanic acid: poor intrinsic antimicrobial activity, suicide inhibitors, well absorbed orally, combined with amoxicillin as oral preparation, and with
inhibitors Ticarcillin as parenteral preparation.
Sulbactam:IM/IV, combined with ampicillin and cepoferazone, high dosages to treat Multi-drug resistant Acinetobacter infections.
Tazobactam: good activity against many plasmid b-lactamases, parenteral, combined with piperacillin and ceftolozane.
Family:
Avibactam: new drug under B-lactamase inhibitors, a Non-B-Lactam B-lactamase inhibitor, useful inhibition against narrow-spectrum, ESBL-type,
chromosomal AmpC, and KPC-type B-lactamases(although not metallo-B-lactamases). Parenteral combination with ceftazidime.